top of page

Prascend (pergolide mesylate), dopamine receptor agonist, is the first and only FDA-approved treatment for the control of clinical signs associated with Pituitary Pars Intermedia Dysfunction (Equine Cushing’s Disease) in horses. Each tablet contains 1 mg of pergolide mesylate. For oral use in horses.

Prascend (pergolide mesylate), 1 mg tab

SKU: 364215376135199
PriceFrom $186.50
  • Prescription items are non-returnable

bottom of page